David Z. Chang

1.6k total citations
19 papers, 1.3k citations indexed

About

David Z. Chang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, David Z. Chang has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in David Z. Chang's work include Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (5 papers) and vaccines and immunoinformatics approaches (4 papers). David Z. Chang is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (5 papers) and vaccines and immunoinformatics approaches (4 papers). David Z. Chang collaborates with scholars based in United States, Australia and China. David Z. Chang's co-authors include James C. Yao, Funda Meric‐Bernstam, Alexandria T. Phan, Carmen Jacob, Jeannette E. Mares, Robert A. Wolff, Sanjay Gupta, Asif Rashid, Kenneth R. Hess and James L. Abbruzzese and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

David Z. Chang

19 papers receiving 1.2k citations

Peers

David Z. Chang

ONCOL

EPIDE

IMMUN

NEURO

Gerald Spöttl Germany

Miranda Payne United Kingdom

Katarina Öhrling Sweden

Damien Kee Australia

Rebecca Ruhl United States

Julie Delyon France

Riccardo Marconcini Italy

D Marrano Italy

Matthew Mei United States

Hironori Tashiro Japan

Gerald Spöttl Germany

David Z. Chang

373 ×0.5

ONCOL

334 ×0.7

EPIDE

135 ×0.4

IMMUN

295 ×0.9

170 ×0.5

NEURO

Citations per year, relative to David Z. Chang David Z. Chang (= 1×) peers Gerald Spöttl

Countries citing papers authored by David Z. Chang

Since Specialization

Citations

This map shows the geographic impact of David Z. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Z. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Z. Chang more than expected).

Fields of papers citing papers by David Z. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Z. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Z. Chang. The network helps show where David Z. Chang may publish in the future.

Co-authorship network of co-authors of David Z. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of David Z. Chang. A scholar is included among the top collaborators of David Z. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Z. Chang. David Z. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Morse, Michael A., Donna Niedzwiecki, John L. Marshall, et al.. (2013). A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer. Annals of Surgery. 258(6). 879–886. 107 indexed citations

Chang, David Z., Ying Ma, Baoan Ji, et al.. (2012). Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. Journal of Hematology & Oncology. 5(1). 15–15. 104 indexed citations

Chang, David Z.. (2012). Mast cells in pancreatic ductal adenocarcinoma. OncoImmunology. 1(5). 754–755. 7 indexed citations

Chang, David Z., Ying Ma, Baoan Ji, et al.. (2011). Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 17(22). 7015–7023. 119 indexed citations

Bernatchez, Chantale, Kuichun Zhu, Yufeng Li, et al.. (2011). Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals. Vaccine. 29(16). 3021–3030. 10 indexed citations

Zhou, Yuhong, David Z. Chang, Joseph S. Chiang, et al.. (2009). Multiple Myeloma, Painful Neuropathy, Acupuncture?. American Journal of Clinical Oncology. 32(3). 319–325. 21 indexed citations

Thapa, Prakash, Guodong Zhang, Chengfeng Xia, et al.. (2009). Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy. Vaccine. 27(25-26). 3484–3488. 61 indexed citations

Yao, James C., Alexandria T. Phan, David Z. Chang, et al.. (2008). Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study. Journal of Clinical Oncology. 26(26). 4311–4318. 495 indexed citations

Tsuda, Naotake, David Z. Chang, Takashi Mine, et al.. (2007). Taxol Increases the Amount and T Cell–Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells. Cancer Research. 67(17). 8378–8387. 29 indexed citations

10.

Zhu, Kuichun, Hong Qin, Soung-Chul Cha, et al.. (2007). Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models. Vaccine. 25(46). 7955–7961. 39 indexed citations

11.

Chun, Yun Shin, Jean‐Nicolas Vauthey, Dario Ribero, et al.. (2007). Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases: Perioperative Safety and Survival. Journal of Gastrointestinal Surgery. 11(11). 1498–1505. 106 indexed citations

12.

Chang, David Z., Kuichun Zhu, Scott Kopetz, et al.. (2007). Presence of survivin-specific cytotoxic T-lymphocytes (CTLs) in pancreatic cancer patients, and specific killing of human pancreatic carcinoma cells in vitro by survivin-specific CTLs. Journal of Clinical Oncology. 25(18_suppl). 3070–3070. 1 indexed citations

13.

Yao, James C., Alexandria T. Phan, David Z. Chang, et al.. (2007). Phase II study of RAD001 (everolimus) and depot octreotide (sandostatin LAR) in advanced low grade neuroendocrine carcinoma (LGNET). Journal of Clinical Oncology. 25(18_suppl). 4503–4503. 19 indexed citations

14.

Chang, David Z.. (2007). The current status of vaccine development in colorectal cancer.. PubMed. 5(2). 109–11, 136. 1 indexed citations

15.

Zhu, Kuichun, Gregory Lizée, Pedro Cano, et al.. (2006). HLA-A0201 positive pancreatic cell lines: new findings and discrepancies. Cancer Immunology Immunotherapy. 56(5). 719–724. 2 indexed citations

16.

Yao, James C., Alexandria T. Phan, David Z. Chang, et al.. (2006). Phase II study of RAD001 (everolimus) and depot octreotide (Sandostatin LAR) in patients with advanced low grade neuroendocrine carcinoma (LGNET). Journal of Clinical Oncology. 24(18_suppl). 4042–4042. 30 indexed citations

17.

Chang, David Z., et al.. (2004). Granulocyte-Macrophage Colony Stimulating Factor: An Adjuvant for Cancer Vaccines. Hematology. 9(3). 207–215. 57 indexed citations

18.

Chang, David Z., Zining Wu, & Thomas L. Ciardelli. (1996). A Point Mutation in Interleukin-2 That Alters Ligand Internalization. Journal of Biological Chemistry. 271(23). 13349–13355. 23 indexed citations

19.

Chang, David Z., et al.. (1994). Mutagenic Analysis of a Receptor Contact Site on Interleukin-2: Preparation of an IL-2 Analog with Increased Potency. Biochemistry. 33(21). 6571–6577. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact